permission

Bio & Pharma Daewoong wins permission for Nabota in Argentina

South Korea's Daewoong Pharmaceutical Co. announced on Monday that its botulinum toxin Nabota received product approval from Argentina's National Ad...

Energy US court rules in favor of Korea's nuclear reactor exports

A US district court on Monday dismissed Westinghouse Electric Corp.’s lawsuit against South Korean state-run companies to block their nuclear ...

Bio & Pharma Daewoong Pharma wins permission from Singapore for Nabota

South Korea's drug development company Daewoong Pharmaceutical said on Thursday that it received on Jan. 20 product approval for its botulinum toxin...

Bio & Pharma Celltrion Healthcare launches anti-cancer biosimilar Vegzelma in Japan

Celltrion Healthcare Co. Ltd. said on Thursday that it launched Vegzelma, a biosimilar to the anti-cancer drug Avastin (active ingredient: bevacizum...

Biosimilars Samsung Bioepis gets nod for sale of ophthalmology biosimilar in Europe

South Korea’s biopharmaceutical company Samsung Bioepis Co. won approval from European authorities for sale of Byooviz, its ophthalmology bios...